Aurora Cannabis and UFC® Join Forces to Advance CBD Research, Education, and Product Development – PRNewswire

Aurora Cannabis and UFC® Join Forces to Advance CBD Research, Education, and Product Development - PRNewswire
UFC inks multi-year, multi-million dollar CBD partnership with Aurora Cannabis
Share Share UFC inks multi-year, multi-million dollar CBD partnership with Aurora Cannabis tweet share Reddit Pocket Flipboard Email Esther Lin Hey, remember when Nate Diaz whipped out his E-pen and started vaping at the UFC 202 press conference and USADA lost its shit?

Thats because the worlds preeminent combat sports promotion just inked a multi-year, multi-million dollar partnership with Aurora Cannabis to help lead continued research into the health benefits of cannabidiol (CBD).

UFC gets in the octagon with Aurora Cannabis in multi-million dollar partnership

This global partnership places focus squarely on the health and well-being of UFCs talented and highly trained athletes, said Aurora Chief Executive Terry Booth. The Aurora-UFC research partnership creates a global platform to launch targeted educational and awareness campaigns, while creating numerous opportunities to accelerate our global CBD business.

The clinical studies are to focus on pain management, inflammation, injury/exercise recovery, and mental well-being. Dr. Jason Dyck, Professor at the University of Alberta, will lead the research. He is a Canada Research Chair in Molecular Medicine and serves as an independent director on the board of Aurora Cannabis.

Marijuana Stocks Rise As Knockout UFC Deal Boosts Wellness Hopes

The research will be conducted at the promotions Performance institute in Las Vegas, focusing on pain management, inflammation, recovery and mental health. In other words, UFC has found yet another reason to lock the doors and block the stairs.

Aurora Cannabis was up 3.5% at 8.48 on the stock market today. It has an IBD Composite Rating of 54, and is trading below its 50-day line. Among other marijuana stocks, Tilray (TLRY), the first pure-play marijuana IPO on the Nasdaq, rose 1.3%, Cronos Group (CRON) surged 6% and Canopy Growth (CGC) climbed 3.4%.

The Edmonton-based cannabis producer said it will work with the fight leagues athletes in clinical studies involving pain management, inflammation, injury, exercise recovery, and mental well-being.

Aurora Cannabis (ACB) was higher Tuesday on the news it has inked a research deal into athlete wellness with the UFC. Meanwhile fellow marijuana stock Innovative Industrial Properties (IIPR) has acquired two buildings in Pennsylvania for the production of medical cannabis.

Cannabidiol or CBD is a wellness-oriented cannabis compound increasingly being infused into everything from coffee to bath bombs.

CBD is believed to, and is often used to, reduce anxiety, induce sleep and have anti-inflammatory effects — without the psychoactive punch of THC. Market research firm Brightfield estimates that U.S. CBD sales will stretch 55% higher to $648 million in 2019.

This global partnership places focus squarely on the health and well-being of UFCs talented and highly trained athletes, Aurora CEO Terry Booth wrote in a news release on Tuesday.

The Aurora-UFC research partnership creates a global platform to launch targeted educational and awareness campaigns, while creating numerous opportunities to accelerate our global CBD business.

Aurora Cannabis said research into CBD products will be conducted at the UFCs Performance Institute in Las Vegas. It will be carried out in collaboration with the UFCs sports performance team and athletes who choose to participate in the studies.

Auroras research will be led by Dr. Jason Dyck, a professor at the University of Alberta and a Canada Research Chair in molecular medicine. He also serves as an independent director on Auroras board.

Meanwhile marijuana REIT Innovative Industrial Properties, which leads marijuana stocks with a 98 Composite Rating, has inked a $13 million deal to buy a two-building property in Saxton, Penn. It comes with 266,000 square feet of industrial space.

Since the day we opened the Performance Institute, our primary goal was to offer UFC athletes the best possible training, nutrition, and recovery services, UFC President Dana White added in the release.

This partnership with Aurora is an extension of that goal, and were looking forward to collaborating with Aurora to find new ways to improve the health and safety of athletes who compete in UFC.

“The Aurora-UFC research partnership creates a global platform to launch targeted educational and awareness campaigns, while creating numerous opportunities to accelerate our global CBD business,” Booth said in a news release.

The move follows Canopy Growth Corp.s (WEED.TO) partnership with the NHL Alumni Association. Canopy announced in March that it would conduct a double-blind clinical trial involving about 100 former hockey stars aimed at reducing reliance on highly-addictive opioids and other pharmaceutical painkillers.


Posted in Aurora